--:--:--

Kwality Pharmaceuticals Limited

Web: kwalitypharma.com NSE: KPL BSE: 539997 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

3431 65(2%)

Volume

29k as on 19, Jun

Open

860

High

894

Low

860

Close

3,366

VWAP

2,448

52 Week High

3,949

52 Week Low

1,561

Viand Research Rating
Quality Score

76/100

Growth Score

100/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

3,560

No. of Shares

1.04

P/E

32.41

P/B

4.17

Face Value

10

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

12.86

ROCE

-

Profit Growth

-

Listing Date

Rank/Sector Rank

#976/#88

Promoter Holding

54.86%

FII Holding

3.13%

DII Holding

0.56%

Price Chart
Price Performance
1 Week0%
1 Month24%
3 Months49%
6 Months49%
1 Year49%
YTD49%
Moving Average
5 Day SMA2,402
10 Day SMA2,398
20 Day SMA2,334
30 Day SMA2,162
50 Day SMA0
61 Day SMA0
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 32,5082,3732,4492,528
Resistance 22,4492,3632,4062,459
Resistance 12,3962,3532,3802,416
Pivot Point2,3372,3432,3372,347
Support 12,2842,3322,2942,304
Support 22,2252,3222,2682,235
Support 32,1722,3122,2252,192
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,18,69817450%5%4%4%3755.50.0711509
2DIVISLAB2,43,96691902%0%45%38%6955.502568
3TORNTPHARM1,73,20845542%5%10%28%7255.51.792138
4ZYDUSLIFE1,11,45111170%1%20%12%2055.50.313560
5APOLLOHOSP1,09,27676002%9%4%1%5855.50.92003
6LAURUSLABS1,08,73820121%8%83%124%055.50.48890
7CIPLA1,06,15413142%2%8%19%2255.50.023862
8DRREDDY1,03,87312443%8%1%4%2055.50.24158
9MANKIND94,40122864%1%8%7%4955.50.391938
10AUROPHARMA90,84115792%1%20%52%055.50.192415
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021
Promoters(0.01) 54.86%(0.01) 54.87%(0.01) 54.82%(0.01) 54.82%(0.01) 54.82%(0.01) 54.82%(0.01) 54.82%(0.01) 54.82%(0.01) 54.82%(0.11) 54.82%(0.01) 54.76%(0.01) 54.76%(0.01) 54.73%(0.31) 54.73%(0.01) 54.44%(0.01) 54.44%(0.01) 54.45%(0.21) 54.43%(0.01) 54.24%
FIIs(0.31) 3.13%(2.31) 2.79%(0.51) 0.50%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%
DIIs(0.21) 0.56%(0.01) 0.36%(0.01) 0.33%(0.01) 0.33%(0.01) 0.33%(0.31) 0.32%(0.01) 0.03%(0.01) 0.02%(0.01) 0.00%(0.01) 0.00%(0.01) 0.01%(0.01) 0.01%(0.01) 0.01%(0.01) 0.01%(0.01) 0.01%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%
Public41.45%41.99%44.33%44.83%44.86%44.86%45.14%45.15%45.18%45.17%45.22%45.22%45.25%45.25%45.54%45.56%45.55%45.57%45.76%
No. of Shareholders13,27910,55510,70911,59510,1159,4208,9477,4875,2735,6955,7866,2916,9436,2115,3764,1981,049581379
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Sales16215712311111111684908092787067695656706488.19183.74
Sales Growth % (YoY)45.6%35.6%46.2%23.6%39.2%25.8%8.1%29.3%18.7%33.7%39.4%24.5%-3.9%7.4%-36.3%-69.6%-41.6%---
Sales Growth % (QoQ)3.2%27.6%10.8%--4.3%38.1%-6.7%12.5%-13%17.9%11.4%4.5%-2.9%23.2%--20%9.4%-27.4%-52%-
Expenses1211189386879067706371615454574140524863.66100.35
Operating Profit41393025242618201721171514111516181624.5383.39
OPM %25252423222221222223212220172728262527.8145.38
Other Income110101100-7100-1501020.840.12
Interest3323322323322221110.50.71
Depreciation5555555545555444333.22.66
Profit before tax34322218171911131161087-101012141421.6780.14
Tax %25202823302425332528212425-242819252526.7725.61
Net Profit 2625161412149884865-779111015.8659.62
Net Profit Growth % (QoQ)4%56.2%14.3%16.7%-14.3%55.6%12.5%-100%-50%33.3%20%171.4%-200%-22.2%-18.2%10%-36.9%-73.4%-
Net Profit Growth % (YoY)116.7%78.6%77.8%75%50%250%12.5%33.3%60%157.1%14.3%-33.3%-54.5%-170%-55.9%-84.9%----
TTM Net Profit81675649433929282623121114203745.8696.4885.4875.480
EPS in Rs24.724.3715.4313.6111.513.978.238.188.074.347.426.035.25-7.116.849.0810.1610.1215.2957.48
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
Sales50337030725145626113816513795765260
Sales Growth %35.9%20.5%22.4%-45%75.1%88.1%-15.9%20.6%43.7%25.5%44.8%-12.2%-
Expenses38529024119028423112414912586704956
Operating Profit118806761172291415129644
OPM %24222224381110989876
Other Income22-5-14424112010
Interest1110107333222111
Depreciation201820151164332211
Profit before tax9054312616222111186322
Tax %25262424262924313841392947
Net Profit 67402419120158853211
Net Profit Growth %67.5%66.7%26.3%-84.2%700%87.5%-60%66.7%50%100%--
EPS in Rs64.9138.4423.1118.76115.714.868.127.284.513.311.891.320.93
Dividend Payout %0000000009000
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
Cash from Operating Activity17534342592661204-31-1
Cash from Investing Activity-35-28-26-48-63-23-17-11-6-7-2-1-3
Cash from Financing Activity7-14-1716112-255513
Net Cash Flow-11100-5241-1-1100-1
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
Equity Capital10101010101010101010105544
Reserves3232802552312161921725237282121181513
Borrowings13011011210398905441352826191386
Other Liabilities13277725074711066553404127171012
Total Liabilities5964784513943983643431691351079872523835
Fixed Assets154144144138138120915642281916111113
CWIP170000141230000000
Investments404044498897541
Other Assets42133430325625622623610286717050362322
Total Assets5964784513943983643431691351079872523835
Delivery

Delivery Data: KPL

#Date
3137
26%
3949
Value (Cr)Q/T
6		Del
42		Del
11
121-Oct3427
15
5467
219-Oct3366
10
5394
316-Oct3403
8
4403
415-Oct3316
19
6499
514-Oct3394
8
6585
613-Oct3533
9
5444
712-Oct3566
5
6563
89-Oct3564
5
4442
98-Oct3533
10
6505
107-Oct3681
8
5454
116-Oct3745
11
6556
125-Oct3644
8
5484
131-Oct3564
15
5457
1430-Sep3641
5
5462
1529-Sep3625
7
5292
1628-Sep3577
10
5424
1725-Sep3672
12
5395
1824-Sep3642
13
5365
1923-Sep3724
15
6416
2022-Sep3753
22
6378
2121-Sep3845
65
73120
2218-Sep3471
10
5414
2317-Sep3452
7
4433
2416-Sep3356
27
53810
2515-Sep3431
21
6388
2611-Sep3643
15
6406
2710-Sep3512
6
5433
289-Sep3577
16
6417
298-Sep3661
59
83320
307-Sep3411
8
6564
314-Sep3286
16
8488
323-Sep3352
7
7433
332-Sep3390
9
6535
341-Sep3390
12
6405
3531-Aug3277
5
5332
3628-Aug3314
6
6402
3727-Aug3267
9
6393
3826-Aug3326
11
8576
3925-Aug3373
15
8477
4024-Aug3452
15
7396
4121-Aug3361
39
84417
4220-Aug3630
26
84111
4319-Aug3452
8
8534
4418-Aug3533
13
7486
4517-Aug3598
37
63814
4614-Aug3436
14
6365
4713-Aug3343
10
6384
4812-Aug3314
16
5264
Daily Market Cap
DateTotal Market CapChangeChg %
21-Oct3,560c44c1.24
19-Oct3,517c38c1.08
17-Oct3,555c00
16-Oct3,555c123c3.60
15-Oct3,431c189c5.21
14-Oct3,620c38c1.03
13-Oct3,658c65c1.76
12-Oct3,723c29c0.79
09-Oct3,694c46c1.25
08-Oct3,648c90c2.41
05-Oct3,739c3c0.08
01-Oct3,742c19c0.49
29-Sep3,760c44c1.19
28-Sep3,716c93c2.45
25-Sep3,809c38c0.98
24-Sep3,847c68c1.74
22-Sep3,915c392c11.13
17-Sep3,523c145c3.95
10-Sep3,668c167c4.77
07-Sep3,501c48c1.38
04-Sep3,453c00
Stock Checklist
Price is above from 52 week high low average: 78%
Stock is trading above all short term SMAs: YES
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: NO
Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Oct26 · Total value ₹0 Cr · 2 increasing / 0 decreasing · View in MF Pro →

Fund HouseSchemesWeight %ChangeValue (Cr)
Bandhan Mutual Fund20.10%+0.02%0
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
For research & education only — not investment advice. Not a SEBI-registered Investment Adviser or Research Analyst. Data may be delayed or inaccurate. Investments in securities markets are subject to market risks.
0